Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

NCT02159859 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease

Interventions

DRUG: Ertapenem

Sponsor

Corewell Health East

Collaborators

[object Object]